Hepatitis C OnlineLogo
Section Navigation
Common TitleENDURANCE-5,6
Official Title Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial.
Phase Phase IIIB
ClinicalTrials.gov NCT02966795
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir

Tradename:MavyretOther Names:GLE-PIBClass:FDA-Approved
Funding
IndustryAbbVie
Open Slide Deck

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.